Bal Pharma Limited (BOM:524824)
86.86
+0.85 (0.99%)
At close: Aug 21, 2026
Bal Pharma Revenue
Bal Pharma had revenue of 890.54M INR in the quarter ending June 30, 2026, with 35.20% growth. This brings the company's revenue in the last twelve months to 3.34B, up 13.42% year-over-year. In the fiscal year ending March 31, 2026, Bal Pharma had annual revenue of 3.12B with 2.83% growth.
Revenue (ttm)
3.34B
Revenue Growth
+13.42%
P/S Ratio
0.41
Revenue / Employee
3.39M
Employees
986
Market Cap
1.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.12B | 85.78M | 2.83% |
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Sat Kartar Life | 2.01B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |